Cas no 10408-89-6 (N-Methyl-1-phenylethanamine hydrochloride)
N-Methyl-1-phenylethanamine hydrochloride Chemical and Physical Properties
Names and Identifiers
-
- N-Methyl-1-phenylethanamine hydrochloride
- Benzenemethanamine, N,.alpha.-dimethyl-, hydrochloride (1:1)
- Methyl(1-phenylethyl)aMine, HCl
- N,α-Dimethylbenzenemethanamine hydrochloride
- Benzylamine, N,alpha-dimethyl-, hydrochloride
- SB45273
- methyl(1-phenylethyl)amine hydrochloride
- Benzenemethanamine, N,alpha-dimethyl-, hydrochloride (1:1)
- MFCD28138033
- BENZYLAMINE, N,.ALPHA.-DIMETHYL-, HYDROCHLORIDE
- CS-0205686
- N-Methyl-1-phenylethylamine hydrochloride
- UNII-IR684460XY
- Methyl (1-phenylethyl)amine hydrochloride
- MFCD09866174
- SY316893
- Q27280860
- N-Methyl-1-phenylethan-1-amine--hydrogen chloride (1/1)
- Methyl(1-Phenylethyl)amine HCl
- DB-032311
- BENZENEMETHANAMINE, N,.ALPHA.-DIMETHYL-, HCL (1:1)
- IR684460XY
- N-methyl-1-phenylethanamine;hydrochloride
- N-Methyl-1-phenylethanaminehydrochloride
- L10186
- AKOS015891446
- AS-19480
- 10408-89-6
- EN300-30239
- DTXSID30639968
-
- MDL: MFCD09866174
- Inchi: 1S/C9H13N.ClH/c1-8(10-2)9-6-4-3-5-7-9;/h3-8,10H,1-2H3;1H
- InChI Key: CLMUXERMQYHMJN-UHFFFAOYSA-N
- SMILES: Cl.N(C)C(C)C1C=CC=CC=1
Computed Properties
- Exact Mass: 171.0814771g/mol
- Monoisotopic Mass: 171.0814771g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 11
- Rotatable Bond Count: 2
- Complexity: 84.7
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 12?2
Experimental Properties
- Melting Point: 72-173 oC
N-Methyl-1-phenylethanamine hydrochloride Security Information
- Signal Word:Warning
- Hazard Statement: H315; H319; H335
- Warning Statement: P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501
- Storage Condition:Store at room temperature
N-Methyl-1-phenylethanamine hydrochloride Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A019064122-250mg |
N-Methyl-1-phenylethan-1-amine hydrochloride |
10408-89-6 | 97% | 250mg |
$680.00 | 2023-09-04 | |
| Alichem | A019064122-500mg |
N-Methyl-1-phenylethan-1-amine hydrochloride |
10408-89-6 | 97% | 500mg |
$980.00 | 2023-09-04 | |
| Alichem | A019064122-1g |
N-Methyl-1-phenylethan-1-amine hydrochloride |
10408-89-6 | 97% | 1g |
$1685.00 | 2023-09-04 | |
| TRC | M339503-25mg |
N-Methyl-1-phenylethanamine hydrochloride |
10408-89-6 | 25mg |
$ 50.00 | 2022-06-02 | ||
| TRC | M339503-50mg |
N-Methyl-1-phenylethanamine hydrochloride |
10408-89-6 | 50mg |
$ 65.00 | 2022-06-02 | ||
| TRC | M339503-250mg |
N-Methyl-1-phenylethanamine hydrochloride |
10408-89-6 | 250mg |
$ 80.00 | 2022-06-02 | ||
| Enamine | EN300-30239-1g |
methyl(1-phenylethyl)amine hydrochloride |
10408-89-6 | 95% | 1g |
$25.0 | 2023-09-06 | |
| Enamine | EN300-30239-5g |
methyl(1-phenylethyl)amine hydrochloride |
10408-89-6 | 95% | 5g |
$47.0 | 2023-09-06 | |
| Enamine | EN300-30239-10g |
methyl(1-phenylethyl)amine hydrochloride |
10408-89-6 | 95% | 10g |
$77.0 | 2023-09-06 | |
| Enamine | EN300-30239-0.05g |
methyl(1-phenylethyl)amine hydrochloride |
10408-89-6 | 95% | 0.05g |
$19.0 | 2023-09-06 |
N-Methyl-1-phenylethanamine hydrochloride Suppliers
N-Methyl-1-phenylethanamine hydrochloride Related Literature
-
1. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imagingGhazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
-
Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
-
Chen Long,Ying Dai,Jianwei Li,Hao Jin Nanoscale, 2020,12, 21124-21130
-
J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
-
Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
Additional information on N-Methyl-1-phenylethanamine hydrochloride
Research Briefing on N-Methyl-1-phenylethanamine Hydrochloride (CAS: 10408-89-6): Recent Advances and Applications
N-Methyl-1-phenylethanamine hydrochloride (CAS: 10408-89-6) is a chemical compound of significant interest in the pharmaceutical and chemical biology fields. This briefing synthesizes the latest research findings, focusing on its synthesis, pharmacological properties, and potential applications. Recent studies have highlighted its role as a key intermediate in the synthesis of novel psychoactive substances (NPS) and its implications in central nervous system (CNS) modulation. The compound's structural similarity to amphetamine derivatives has spurred investigations into its metabolic pathways and receptor interactions, particularly with dopamine and serotonin transporters.
A 2023 study published in the Journal of Medicinal Chemistry explored the enantioselective synthesis of N-Methyl-1-phenylethanamine hydrochloride, demonstrating improved yield and purity through catalytic asymmetric methods. The research emphasized the compound's utility in producing optically active intermediates for antidepressants and stimulants. Additionally, advancements in green chemistry have enabled more sustainable production processes, reducing environmental impact while maintaining high efficacy.
Pharmacological evaluations have revealed that N-Methyl-1-phenylethanamine hydrochloride exhibits moderate affinity for the dopamine D2 receptor, suggesting potential applications in treating neuropsychiatric disorders. However, its abuse potential and regulatory status remain under scrutiny, with the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) flagging it as a substance of concern. Recent in vitro and in vivo studies have also investigated its metabolic stability, identifying cytochrome P450 enzymes as primary mediators of its biotransformation.
In the context of drug discovery, this compound has been leveraged as a scaffold for designing novel analogs with enhanced selectivity and reduced side effects. A 2024 preprint on bioRxiv detailed a high-throughput screening campaign that identified several derivatives with promising activity against treatment-resistant depression. These findings underscore the compound's versatility and the need for continued research to unlock its full therapeutic potential while addressing safety concerns.
In conclusion, N-Methyl-1-phenylethanamine hydrochloride (CAS: 10408-89-6) remains a pivotal compound in chemical biology and pharmaceutical research. Its dual role as a synthetic intermediate and a pharmacologically active agent warrants further exploration, particularly in optimizing its therapeutic index and mitigating risks associated with misuse. Collaborative efforts between chemists, pharmacologists, and regulatory bodies will be essential to harness its benefits responsibly.
10408-89-6 (N-Methyl-1-phenylethanamine hydrochloride) Related Products
- 5933-40-4((R)-N-Methyl-1-phenylethanamine)
- 19131-99-8((S)-(-)-N-Methyl-1-phenylethylamine)
- 19302-37-5(benzyl(1S)-1-phenylethylamine hydrochloride)
- 32512-24-6(methyl(1-phenylethyl)amine)
- 49746-32-9(benzyl(1-phenylethyl)amine hydrochloride)
- 40648-92-8((S,S)-(-)-Bis(α-methylbenzyl)amine Hydrochloride)
- 82398-30-9((aR)-a-Methyl-N-(1R)-1-phenylethylbenzenemethanamine Hydrochloride)
- 42287-48-9(Benzenemethanamine, a-methyl-N-[(1R)-1-phenylethyl]-,(aR)-rel-)
- 116297-12-2((S)-(-)-N-Isopropyl-1-phenylethylamineHydrochloride)
- 128593-72-6((R)-(+)-N-Isopropyl-1-phenylethylamineHydrochloride)